Претраживање
Приказ резултата 11-20 од 162
Investigation of the impact of pharmaceutical care on improvement of treatment knowledge and inhalation technique in asthma patients / Istraživanje značaja farmaceutske zdravstvene zaštite u unapređenju znanja o inhalacionoj terapiji i njenoj pravilnoj primeni kod pacijenata sa astmom
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Introduction: Insufficient patient knowledge about asthma treatment and inappropriate inhalation techniques contribute to treatment failure. The aim of this study was to investigate the impact of a pharmaceutical care ...
Labelling of stock preparations and extemporaneous drugs: National and international legislation and practices / Obeležavanje galenskih i magistralnih lekova - nacionalni i međunarodni propisi i praksa
(Savez farmaceutskih udruženja Srbije, Beograd, 2014)
The pharmaceutical industry has provided drug production of uniform quality, safety and efficacy, and the same is necessary for the preparation of stock preparations and extemporaneous drugs. Therefore, this type of ...
Characteristics and application of chitosan in pharmaceutical/biomedical preparations / Karakteristike i primena hitozana u farmaceutskim/biomedicinskim preparatima
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Chitosans are binary linear heteropolysaccharides derived from chitin by its partial deacetylation. Due to unique cationic nature these biopolymers have enormous potential in pharmacy and biomedicine. This potential is ...
Medicines in treatment of addictive disorders / Lekovi u terapiji bolesti zavisnosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
It is estimated that annual sales of illegal psychoactive substances account for 8% of total international trade. The large consumption of alcohol and tobacco, as socially accepted drugs, as well as of several classes of ...
Sex differences in the clinical presentation and therapy of multiple sclerosis / Polne razlike u kliničkoj slici i terapiji multiple skleroze
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Multiple sclerosis (MS) is more prevalent in women than in men, with the female to male ratio in the prevalence of MS constantly increasing. Besides, sex appears to affect the development, progression, clinical manifestation ...
Biopharmaceutical aspects of ciprofloxacin interactions with metallic ions / Biofarmaceutski aspekti interakcije ciprofloksacina i jona metala
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
The ciprofloxacin - metallic ions interactions are well documented and described in the literature. In vivo studies show that ciprofloxacin bioavailability is reduced in the presence of metallic ions containing preparations. ...
Lipid status in phyisiological non-complicated pregnancy / Lipidni status fiziološke nekomplikovane trudnoće
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Specifically altered lipid profile and physiological hyperlipidemia during pregnancy are considered essential for the normal course of pregnancy and fetal development. This specific alteration of the lipid profile raises ...
Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin / Farmakoekonomska evaluacija pružanja farmaceutske usluge pacijentima na antikoagulantnoj terapiji varfarinom
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
It has been determined that Pharmacist-Managed Anticoagulation Service (PMAS) for patients on warfarin improves anticoagulation control and decreases the rate of bleeding, thus reducing the overall health care costs. This ...
Drugs for rare diseases: An example of modified glucocerebrosidase / Lekovi za retke bolesti - primer modifikovane glukocerebrozidaze
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
To date, circa 5000 rare diseases have been defined, which in sum affect approximately 6% of total population. The development of drugs for rare diseases is hampered by the limitation of specific knowledge availability and ...
Pharmacology of oral hypoglycemic drugs / Farmakologija oralnih hipoglikemijskih lekova
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
In patients with diabetes mellitus type 2, non-insulin antihyperglycemic therapy is aimed to control symptoms of hyperglycemia and to limit microvascular complications. It is introduced early after diagnosis of the disease. ...